Home > Healthcare & Medical Devices > Intrauterine Devices Market
Intrauterine Devices Market Size, By Product (Copper IUD, Hormonal IUD), By Age Group (15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45+), Industry Analysis Report, Regional Outlook, Growth Potential, Application Potential, Competitive Market Share & Forecast, 2023-2032
- Report ID: GMI5451
- Published Date: Mar 2023
- Report Format: PDF
Industry Statistics
Intrauterine Devices Market size was valued at over USD 4 billion in 2022. Driven by the growing instances of unwanted pregnancies across the globe, the market is slated to grow at over 6% CAGR from 2023 to 2032.
Get more details on this report - Request Free Sample PDF
As per the UN’s sexual and reproductive health agency, UNFPA, the world reports about 121 million unwanted pregnancies annually, which represents nearly 50% of all pregnancies. Many of such pregnancies occur due to reproductive coercion, sexual violence, unawareness about sexual and reproductive healthcare, resulting in various health complications and financial implications.
Meanwhile, growing awareness about family planning has also increased the demand for intrauterine devices in recent years. These devices are reliable for contraception and can last for up to 5 years or more. They are also easy to use, reversible in nature, efficient, and ideal for long-term use.
| Report Coverage | Details |
|---|---|
| Base Year: | 2022 |
| Market Size in 2022: | USD 4 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 6% |
| 2032 Value Projection: | USD 7.5 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 170 |
| Tables, Charts & Figures: | 205 |
| Segments covered: | Product, Age Group, and Region. |
| Growth Drivers: | |
| Pitfalls & Challenges: |
Get more details on this report - Request Free Sample PDF
Health complications related to IUDs may restrain industry development
Despite various benefits offered by IUDs, the potential health risks associated with their regular use may impede product adoption, hampering intrauterine devices market progress. Studies have shown that an IUD may slightly increase the chances of infection to the fallopian tubes, uterus, or ovaries, resulting in pelvic inflammatory disease (PID). In fact, as per the NCBI, chances of PID are 2-5 times higher in IUD users, specifically common in women aged between 15-19 than in women who use other contraception methods such as barrier technique or oral contraceptives.
Long-term contraception of hormonal IUD to spur product segment expansion
Get more details on this report - Request Free Sample PDF
Based on product, the intrauterine devices market share from hormonal IUD segment is poised to depict a CAGR of more than 6.5% over 2023 - 2032. Hormonal IUDs such as Mirena™ and Kyleena™ can be used for up to 5 years without complications. They are regarded as quite safe and are suitable for people with heavy menstrual flow, fibroids, anemia, and endometriosis. In fact, there have been very few instances where users have experienced vaginal bleeding after its insertion. The other benefits of hormonal IUDs include less painful menstrual cycles, low risk of pelvic inflammatory disease (PID), less bleeding, and long-term contraception, among others.
Increasing abortion rates to propel 30-34 age group segment development
| Segment | Global market share, 2022 (%) |
|---|---|
| 15-19 | 7.1% |
| 20-24 | 13.5% |
| 25-29 | 22.6% |
| 30-34 | 27.2% |
| 35-39 | 16.5% |
| 40-44 | 7.6% |
| 45+ | 5.6% |
Get more details on this report - Request Free Sample PDF
Intrauterine devices market from the 30-34 age group segment is poised to cross over USD 2 billion by 2032, on account of the growing incidences of unwanted pregnancies and abortions among women of this age group. Moreover, at the age of 30, women have a higher chance of successfully conceiving. This, when combined with rising awareness among women about various IUDs and their applications, makes this segment one of the most prominent consumers of the product.
Surging spending on healthcare to strengthen Asia Pacific industry landscape
Get more details on this report - Request Free Sample PDF
Asia Pacific intrauterine devices market is expected to grow at over 6.5% CAGR through 2032, driven by the growing investments in the region’s healthcare sector. Recently, for the Union Budget of India for 2022-23, over USD 11.28 billion were allocated to the Ministry of Health and Family Welfare (MoHFW). Many governments in the region are taking more efforts to reduce the cost of existing intrauterine devices in the market while also making superior quality IUDs easily accessible, creating a positive outlook for regional market forecasts.
Partnerships to outline the competitive landscape
The list of prominent intrauterine devices market players includes names such as Pregna International Ltd., Allergan (AbbVie Inc.), OCON Medical Ltd., HLL Lifecare Limited, Durbin, SMB Corporation of India, and Eurogine S.L., among others. Many of these players are focusing on partnerships to enhance their market position. Citing an instance, in December 2022, CooperSurgical, Inc., a US-based supplier of medical products, inked a partnership agreement with Ostro, a prominent engagement platform, to educate customers about its non-hormone intrauterine device, Paragard, which is also FDA-cleared IUD for pregnancy prevention.
This strategic move also helped the company employ the latest of technologies in its portfolio, making a live nurse navigator available to the women using Paragard. This helped it outperform its competitors technologically and broaden its customer base.
Impact of COVID-19 on intrauterine devices market trends
The COVID-19 pandemic impacted the intrauterine devices industry negatively on account of supply chain disruptions and restrictions in 2020. Demand for intrauterine contraceptives reduced specifically during the first lockdown but increased moderately at the end of 2020 and through 2021. Due to prolonged lockdowns and travel restrictions, product adoption was also hampered in gynecology hospitals and clinics. However, with the reduced infection rates of COVID-19 in several nations in 2021, the demand for IUDs was restored due to the resumption social activities.
The intrauterine devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD and units from 2018 to 2032, for the following segments:
By Product
- Copper IUD
- Hormonal IUD
By Age Group
- 15-19
- 20-24
- 25-29
- 30-34
- 35-39
- 40-44
- 45+
The above information is provided for the following regions and countries:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Poland
- Switzerland
- The Netherlands
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Indonesia
- Thailand
- Vietnam
- Latin America
- Brazil
- Mexico
- Argentina
- Chile
- Colombia
- Peru
- Middle East & Africa
- South Africa
- Saudi Arabia
- Nigeria
- Turkey
- Iran
- Egypt